Prevalence of cardiovascular disease events and determinants in patients with x-linked hypophosphatemia

Prevalence of cardiovascular disease events and determinants in patients with x-linked hypophosphatemia

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Maronga, C, Javaid, MK, Pinedo Villanueva, R
Μορφή:	Conference item
Γλώσσα:	English
Έκδοση:	Springer Nature 2023

Παρόμοια τεκμήρια

Prevalence and risk factors of hypertension among patients with X-linked hypophosphatemia
ανά: Maronga, C, κ.ά.
Έκδοση: (2023)

A literature review of the healthcare resource use and productivity burden of X-linked hypophosphatemia
ανά: Pinedo Villanueva, R, κ.ά.
Έκδοση: (2023)

Increased prevalence of overweight and obesity in children with X-linked hypophosphatemia
ανά: Volha V Zhukouskaya, κ.ά.
Έκδοση: (2020-02-01)

Dental management of patients with X-linked hypophosphatemia
ανά: Bin-Na Lee, κ.ά.
Έκδοση: (2017-05-01)

Prevalence and clinical characteristics of X-linked hypophosphatemia in Paraná, southern Brazil
ανά: Carolina Aguiar Moreira, κ.ά.
Έκδοση: (2020-10-01)

Treatment of X-Linked Hypophosphatemia in Children
ανά: Toshihiro Tajima, κ.ά.
Έκδοση: (2022-08-01)

Adult Presentation of X-Linked Hypophosphatemia
ανά: Nobuaki Ito
Έκδοση: (2022-07-01)

Special Issue: “X-Linked Hypophosphatemia”
ανά: Seiji Fukumoto, κ.ά.
Έκδοση: (2023-11-01)

Craniosynostosis in Patients With X‐Linked Hypophosphatemia: A Review
ανά: Craig F Munns, κ.ά.
Έκδοση: (2023-05-01)

FURTHER LOCALIZATION OF THE GENE FOR X-LINKED HYPOPHOSPHATEMIA
ανά: Read, A, κ.ά.
Έκδοση: (1987)

Complications and Treatments in Adult X-Linked Hypophosphatemia
ανά: Yasuo Imanishi, κ.ά.
Έκδοση: (2022-09-01)

X-Linked Hypophosphatemia Transition and Team Management
ανά: Takuo Kubota
Έκδοση: (2022-07-01)

Presentation and Diagnosis of Pediatric X-Linked Hypophosphatemia
ανά: Kento Ikegawa, κ.ά.
Έκδοση: (2023-02-01)

Hereditary X-Linked Hypophosphatemia and Thoracic Myelopathy
ανά: George Forrest, MD, κ.ά.
Έκδοση: (2016-01-01)

Cardiovascular health in pediatric patients with X-linked hypophosphatemia under two years of burosumab therapy
ανά: Avivit Brener, κ.ά.
Έκδοση: (2024-05-01)

Mutational analysis of PHEX gene in X-linked hypophosphatemia.
ανά: Dixon, P, κ.ά.
Έκδοση: (1998)

Health-related quality of life and a cost-utility simulation of adults in the UK with osteogenesis imperfecta, X-linked hypophosphatemia and fibrous dysplasia
ανά: Forestier-Zhang, L, κ.ά.
Έκδοση: (2016)

X-linked hypophosphatemia attributable to pseudoexons of the PHEX gene.
ανά: Christie, P, κ.ά.
Έκδοση: (2001)

Burosumab and Dental Abscesses in Children With X‐Linked Hypophosphatemia
ανά: Margaux Gadion, κ.ά.
Έκδοση: (2022-11-01)

Orthopedic Complications and Management in Children with X-Linked Hypophosphatemia
ανά: Chikahisa Higuchi
Έκδοση: (2022-08-01)

Dental Manifestations and Oral Management of X-Linked Hypophosphatemia
ανά: Rena Okawa, κ.ά.
Έκδοση: (2022-10-01)

Dental health of patients with X-linked hypophosphatemia: A controlled study
ανά: Amila Larsson, κ.ά.
Έκδοση: (2023-03-01)

An adult patient of X-linked hypophosphatemia with joint manifestation mimicking spondylarthritis
ανά: Chuhan Wang, κ.ά.
Έκδοση: (2022-05-01)

Clinical and genetic characteristics of 29 Chinese patients with X-linked hypophosphatemia
ανά: Tian Xu, κ.ά.
Έκδοση: (2022-08-01)

Health-related quality of life of X-linked hypophosphatemia in Spain
ανά: M. I. Luis Yanes, κ.ά.
Έκδοση: (2022-07-01)

The Metabolic Bone Disease X-linked Hypophosphatemia: Case Presentation, Pathophysiology and Pharmacology
ανά: Jon Vincze, κ.ά.
Έκδοση: (2021-06-01)

Pathogenesis of FGF23-Related Hypophosphatemic Diseases Including X-linked Hypophosphatemia
ανά: Tatsuro Nakanishi, κ.ά.
Έκδοση: (2022-06-01)

Evaluation of dental manifestations in X-linked hypophosphatemia using orthopantomography.
ανά: Rena Okawa, κ.ά.
Έκδοση: (2024-01-01)

Insights into the Molecular and Hormonal Regulation of Complications of X-Linked Hypophosphatemia
ανά: Supriya Jagga, κ.ά.
Έκδοση: (2023-03-01)

Phenotypic characterization of X-linked hypophosphatemia in pediatric Spanish population
ανά: Enrique Rodríguez-Rubio, κ.ά.
Έκδοση: (2021-02-01)

Consensus Recommendations for the Diagnosis and Management of X-Linked Hypophosphatemia in Belgium
ανά: Michaël R. Laurent, κ.ά.
Έκδοση: (2021-03-01)

Subgroups of adults with X-linked hypophosphataemia: cluster analysis of patient-reported outcome measures of participants in a UK rare diseases cohort
ανά: Cole, S, κ.ά.
Έκδοση: (2021)

X-linked hypophosphataemia: prevalence and mortality rate within the United Kingdom Clinical Practice Research Datalink
ανά: Hawley, S, κ.ά.
Έκδοση: (2019)

Expression and cloning of the human X-linked hypophosphatemia gene cDNA.
ανά: Grieff, M, κ.ά.
Έκδοση: (1997)

Impact of burosumab on lower limb alignment in children with X-linked hypophosphatemia
ανά: David B. Frumberg, MD, FAAOS, κ.ά.
Έκδοση: (2024-02-01)

Characteristics of oral health of patients with X-linked hypophosphatemia: case reports and literature review
ανά: Ana Arhar, κ.ά.
Έκδοση: (2024-05-01)

Positive Response to One-Year Treatment With Burosumab in Pediatric Patients With X-Linked Hypophosphatemia
ανά: Silvia Martín Ramos, κ.ά.
Έκδοση: (2020-02-01)

Patient-reported outcomes measures of X-linked hypophosphataemia participants: findings from a prospective cohort study in the UK
ανά: Cole, S, κ.ά.
Έκδοση: (2023)

Expected benefits and budget impact from a microsimulation model support the prioritisation and implementation of fracture liaison services
ανά: Pinedo Villanueva, R, κ.ά.
Έκδοση: (2023)

Lower limb maltorsion and acetabular deformity in children and adolescents with X-linked hypophosphatemia
ανά: Alexandra Stauffer, κ.ά.
Έκδοση: (2024-09-01)